Cargando…
IgM-associated gut bacteria in obesity and type 2 diabetes in C57BL/6 mice and humans
AIMS/HYPOTHESIS: IgM is the primary antibody produced by B cells and we hypothesise that IgM antibodies to gut microbiota may play a role in immunometabolism in obesity and type 2 diabetes. To test our hypothesis, we used B6 mice deficient in activation-induced cytidine deaminase (Aid(−/−) [also kno...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283171/ https://www.ncbi.nlm.nih.gov/pubmed/35587276 http://dx.doi.org/10.1007/s00125-022-05711-8 |
_version_ | 1784747275721900032 |
---|---|
author | Pearson, James A. Ding, Heyuan Hu, Changyun Peng, Jian Galuppo, Brittany Wong, F. Susan Caprio, Sonia Santoro, Nicola Wen, Li |
author_facet | Pearson, James A. Ding, Heyuan Hu, Changyun Peng, Jian Galuppo, Brittany Wong, F. Susan Caprio, Sonia Santoro, Nicola Wen, Li |
author_sort | Pearson, James A. |
collection | PubMed |
description | AIMS/HYPOTHESIS: IgM is the primary antibody produced by B cells and we hypothesise that IgM antibodies to gut microbiota may play a role in immunometabolism in obesity and type 2 diabetes. To test our hypothesis, we used B6 mice deficient in activation-induced cytidine deaminase (Aid(−/−) [also known as Aicda(−/−)]) which secrete only IgM antibodies, and human faecal samples. METHODS: We studied the immunometabolic effects and gut microbial changes in high-fat-diet-induced obesity (HFDIO) in Aid(−/−) B6 mice compared with wild-type mice. To determine similarities between mice and humans, human stool samples were collected from children and adolescents who were obese with normal glucose tolerance (NGT), obese with glucose intolerance (IGT), or obese and newly diagnosed with type 2 diabetes, for faecal microbiota transplant (FMT) into germ-free (GF) B6 mice and we assessed IgM-bound bacteria and immune responses. RESULTS: Compared with wild-type mice, Aid(−/−) B6 mice developed exacerbated HFDIO due to abundant levels of IgM. FMT from Aid(−/−) B6 to GF B6 mice promoted greater weight gain in recipient mice compared with FMT using wild-type mouse faecal microbiota. Obese youth with type 2 diabetes had more IgM-bound gut bacteria. Using the stools from the obese youth with type 2 diabetes for FMT to GF B6 mice, we observed that the gut microbiota promoted body weight gain and impaired glucose tolerance in the recipient GF B6 mice. Importantly, some clinical features of these obese young individuals were mirrored in the GF B6 mice following FMT. CONCLUSIONS/INTERPRETATION: Our results suggest that IgM-bound gut microbiota may play an important role in the immuno-pathogenesis of obesity and type 2 diabetes, and provide a novel link between IgM in obesity and type 2 diabetes in both mice and humans. DATA AVAILABILITY: The 16s rRNA sequencing datasets supporting the current study have been deposited in the NCBI SRA public repository (https://www.ncbi.nlm.nih.gov/sra; accession no. SAMN18796639). GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains peer-reviewed but unedited supplementary material available at 10.1007/s00125-022-05711-8. |
format | Online Article Text |
id | pubmed-9283171 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-92831712022-07-16 IgM-associated gut bacteria in obesity and type 2 diabetes in C57BL/6 mice and humans Pearson, James A. Ding, Heyuan Hu, Changyun Peng, Jian Galuppo, Brittany Wong, F. Susan Caprio, Sonia Santoro, Nicola Wen, Li Diabetologia Article AIMS/HYPOTHESIS: IgM is the primary antibody produced by B cells and we hypothesise that IgM antibodies to gut microbiota may play a role in immunometabolism in obesity and type 2 diabetes. To test our hypothesis, we used B6 mice deficient in activation-induced cytidine deaminase (Aid(−/−) [also known as Aicda(−/−)]) which secrete only IgM antibodies, and human faecal samples. METHODS: We studied the immunometabolic effects and gut microbial changes in high-fat-diet-induced obesity (HFDIO) in Aid(−/−) B6 mice compared with wild-type mice. To determine similarities between mice and humans, human stool samples were collected from children and adolescents who were obese with normal glucose tolerance (NGT), obese with glucose intolerance (IGT), or obese and newly diagnosed with type 2 diabetes, for faecal microbiota transplant (FMT) into germ-free (GF) B6 mice and we assessed IgM-bound bacteria and immune responses. RESULTS: Compared with wild-type mice, Aid(−/−) B6 mice developed exacerbated HFDIO due to abundant levels of IgM. FMT from Aid(−/−) B6 to GF B6 mice promoted greater weight gain in recipient mice compared with FMT using wild-type mouse faecal microbiota. Obese youth with type 2 diabetes had more IgM-bound gut bacteria. Using the stools from the obese youth with type 2 diabetes for FMT to GF B6 mice, we observed that the gut microbiota promoted body weight gain and impaired glucose tolerance in the recipient GF B6 mice. Importantly, some clinical features of these obese young individuals were mirrored in the GF B6 mice following FMT. CONCLUSIONS/INTERPRETATION: Our results suggest that IgM-bound gut microbiota may play an important role in the immuno-pathogenesis of obesity and type 2 diabetes, and provide a novel link between IgM in obesity and type 2 diabetes in both mice and humans. DATA AVAILABILITY: The 16s rRNA sequencing datasets supporting the current study have been deposited in the NCBI SRA public repository (https://www.ncbi.nlm.nih.gov/sra; accession no. SAMN18796639). GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains peer-reviewed but unedited supplementary material available at 10.1007/s00125-022-05711-8. Springer Berlin Heidelberg 2022-05-19 2022 /pmc/articles/PMC9283171/ /pubmed/35587276 http://dx.doi.org/10.1007/s00125-022-05711-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Pearson, James A. Ding, Heyuan Hu, Changyun Peng, Jian Galuppo, Brittany Wong, F. Susan Caprio, Sonia Santoro, Nicola Wen, Li IgM-associated gut bacteria in obesity and type 2 diabetes in C57BL/6 mice and humans |
title | IgM-associated gut bacteria in obesity and type 2 diabetes in C57BL/6 mice and humans |
title_full | IgM-associated gut bacteria in obesity and type 2 diabetes in C57BL/6 mice and humans |
title_fullStr | IgM-associated gut bacteria in obesity and type 2 diabetes in C57BL/6 mice and humans |
title_full_unstemmed | IgM-associated gut bacteria in obesity and type 2 diabetes in C57BL/6 mice and humans |
title_short | IgM-associated gut bacteria in obesity and type 2 diabetes in C57BL/6 mice and humans |
title_sort | igm-associated gut bacteria in obesity and type 2 diabetes in c57bl/6 mice and humans |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283171/ https://www.ncbi.nlm.nih.gov/pubmed/35587276 http://dx.doi.org/10.1007/s00125-022-05711-8 |
work_keys_str_mv | AT pearsonjamesa igmassociatedgutbacteriainobesityandtype2diabetesinc57bl6miceandhumans AT dingheyuan igmassociatedgutbacteriainobesityandtype2diabetesinc57bl6miceandhumans AT huchangyun igmassociatedgutbacteriainobesityandtype2diabetesinc57bl6miceandhumans AT pengjian igmassociatedgutbacteriainobesityandtype2diabetesinc57bl6miceandhumans AT galuppobrittany igmassociatedgutbacteriainobesityandtype2diabetesinc57bl6miceandhumans AT wongfsusan igmassociatedgutbacteriainobesityandtype2diabetesinc57bl6miceandhumans AT capriosonia igmassociatedgutbacteriainobesityandtype2diabetesinc57bl6miceandhumans AT santoronicola igmassociatedgutbacteriainobesityandtype2diabetesinc57bl6miceandhumans AT wenli igmassociatedgutbacteriainobesityandtype2diabetesinc57bl6miceandhumans |